Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need.
Applied Therapeutics leverages technological advances to target molecules and pathways with proven roles in disease biology.
By applying the right science and the right development strategies, Applied Therapeutics aims to rapidly advance new treatments for patients with high unmet medical need.
Applied Therapeutics is building a pipeline of novel drugs to treat diseases with no treatment options. Our Aldose Reductase Inhibitor (ARI) franchise is in development across multiple disease areas, including Galactosemia, SORD Deficiency, Diabetic Cardiomyopathy and other diseases.
Our mission is to create transformative treatments for patients with high unmet need conditions.
By applying the right science and the right development strategies, Applied Therapeutics aims to rapidly advance new treatments for patients with high unmet medical need.
©2020 Applied Therapeutics All Rights Reserved
